Pfizer
Jean-Marc N. has an extensive work experience in various companies and roles. Jean-Marc is currently working as the Director Team Lead in International Markets Strategy at Pfizer since July 2023. Prior to this, they worked at Boston Consulting Group (BCG) as a Project Leader from June 2022 to July 2023. Jean-Marc also served as a Manager and Consultant in Strategy Planning and Insights at ZS from December 2015 to June 2022. Before that, they held the position of Senior Vice President at AlixPartners from January 2020 to August 2020. Jean-Marc started their career at Capgemini Consulting as a Senior Consultant from July 2013 to December 2015, and as an Audit Associate at PwC from August 2009 to July 2011.
Jean-Marc N. obtained a Bachelor's degree in Accounting and Statistics from Babson College, which they attended from 2006 to 2009. Following this, they pursued an MBA in Decision Science (Statistics) and Finance from Duke University's Fuqua School of Business from 2011 to 2013. Prior to their higher education, they attended Saint-Louis de Gonzague for their secondary education, with a focus on High School/Secondary Diplomas and Certificates, completing it in 2005.
This person is not in any teams
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.